Opendata, web and dolomites


A slow release insemination that doubles the success rate of the most common first line treatment of infertility.

Total Cost €


EC-Contrib. €






Project "EVIE 2.0" data sheet

The following table provides information about the project.


Organization address
address: 37 HAHASHMONAIN ST.
city: RA ANANA
postcode: 4325623
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-02-29


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FERTILIGENT LTD IL (RA ANANA) coordinator 50˙000.00


 Project objective

Infertility impacts 25 million European citizens and 90 million couples globally (1 in 6 couples). Europe’s total fertility rate is among the lowest in the world, at 1.5 children per woman, a figure that is expected to decrease further to 1.2 by 2030 – making it a critical public health issue. Typically, infertility is treated with intrauterine insemination (IUI) or IVF. IUI is the most common first-line treatment as it is non-invasive and relatively cheap, but its success rate of around 7% means that IVF, a far more expensive and invasive procedure, with an overall success rate of around 30% becomes necessary. The market needs an affordable, easily accessible, non-invasive alternative that increases the success rate. EVIE 2.0 is a patent protected, fully automatic slow release insemination device that bypasses the hostile cervix to slowly release sperm into the uterus over four hours via a proprietary balloon catheter and an insemination syringe. Unlike standard Intrauterine Insemination (IUI), EVIE mimics nature by slowly and gently releasing the sperm - maximizing the opportunity for the sperm to reach the egg and increasing the prospect of fertilization - more than doubling the success rate of 7.2% to 18.7% and decreasing the average cost per pregnancy. EVIE 2.0 will transform the infertility market by providing an alternative non-invasive first-line treatment solution with increased success rate, reducing the need for couples to resort to expensive and complex treatments. To have EVIE 2.0 fully projected at a European and global level we need a further investment of €2.5M to complete all product development, scale-up and complete a clinical study. The proposed work in Phase 1 of the SME instrument fits into our overall plan to reach the market by contributing the financial resources needed to plan a fast, sound and widee deployment of EVIE 2.0.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EVIE 2.0" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EVIE 2.0" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

COPI (2020)

Carbon Offset Plug-in

Read More  

Manuback (2019)

MANUBACK, the smart garment for operator protection in the field of Manual Handling of Goods

Read More  

Cortx (2019)

Intelligent debt recovery platform.

Read More